Research and Development

Showing 15 posts of 9607 posts found.

Pfizer

Deaths reported in Pfizer arthritis trial

April 26, 2011 Research and Development, Sales and Marketing Pfizer, rheumatoid arthritis, tofacitinib

Four deaths have been reported in a late-stage study of Pfizer’s arthritis drug tofacitinib. Three of the deaths are thought …

Sten Westerberg joins BioInvent

April 26, 2011 Research and Development appointment, research and development, sales and marketing

Swedish pharma company BioInvent International has appointed Sten Westerberg to the newly-created position of vice president investor relations. Sten is …

UCB and Amgen’s osteoporosis drug shows promise

April 21, 2011 Research and Development Amgen, UCB, osteoporosis

Amgen and UCB have announced strong results from a phase II study of their new postmenopausal osteoporosis treatment. Most existing …

Trevor Smith to lead Takeda in Europe

April 21, 2011 Research and Development, Sales and Marketing appointment, research and development, sales and marketing

Trevor Smith has been appointed chief executive of Takeda Pharmaceuticals Europe. Smith brings more than 30 years of pharmaceutical experience …

Procurement pitfalls and hurdles of lab equipment for clinical trials

April 20, 2011 Research and Development clinical trials, medical equipment, mesm, procurement

 Over $78 billion is spent every year in the clinical trial market in the pursuit of bringing new drugs and …

Novavax appoints Stanley Erck chief executive

April 20, 2011 Research and Development appointment, research and development

US biopharmaceutical company Novavax has reorganised its senior management. The changes see former executive chairman Stanley Erck take on the …

Warner Chilcott plans to axe 500 jobs in Europe

April 20, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Warner Chilcott, pharma job cuts

Warner Chilcott is looking to cut 500 jobs from its European operations as it seeks to minimise the impact of …

Contract research news in brief

April 20, 2011 Research and Development CRO, contract research

Our contract research news round-up features updates from BioClinica, Vyteris, CROMSOURCE, Quintiles, Imperial/D. Anderson and PRA International. Clinical trial management …

Circassia raises funds to develop allergy products

April 19, 2011 Research and Development Circassia, UK biotech, biotech

UK biopharma company Circassia has raised £60 million funding for the final stage of development of its anti-allergy products. The …
Pfizer

Phase III boost for Pfizer’s oral arthritis drug

April 18, 2011 Research and Development, Sales and Marketing Pfizer, rheumatoid arthritis, tofacitinib

Pfizer’s rheumatoid arthritis treatment tofacitinib has induced clinical remission of the disease according to one-year data from a phase III …
Genzyme's headquarters

Genzyme MS drug shines in head-to-head trial with Rebif

April 18, 2011 Research and Development, Sales and Marketing Genzyme, Lemtrada, Sanofi-Aventis, relapsing multiple sclerosis

Genzyme’s multiple sclerosis candidate Lemtrada has impressed in a new phase II head-to-head trial. Five years’ worth of mid-stage data …

GlaxoSmithKline to drop Alli and other OTC products

April 15, 2011 Research and Development, Sales and Marketing Alli, GSK, OTC, Tyverb

GlaxoSmithKline is to sell off its weight loss drug Alli and other less profitable non-prescription drugs. GSK announced its decision …
roche

Roche growth stalls after Avastin setback

April 14, 2011 Research and Development, Sales and Marketing Roche

Revenues at Roche flattened out in the first three months of 2011, as Avastin sales declined in the US and Europe. Group …

Watermeadow continues to grow

April 14, 2011 Research and Development Watermeadow, awards, employees, growth

Watermeadow Medical is delighted to welcome seven new staff to its UK offices. The appointments have been made as demand …
Lonza, Slough

Lonza expands UK facility, bio business reports growth

April 13, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Benlysta, Lonza, Slough, manufacturing

Swiss contract manufacturer and fine chemicals company Lonza has said it plans to expand its biopharmaceutical production unit in Slough, …
The Gateway to Local Adoption Series

Latest content